Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
FRTX was delisted on the 18th of December, 2023.
58 hedge funds and large institutions have $22.5M invested in Fresh Tracks Therapeutics, Inc. Common Stock in 2015 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 21 increasing their positions, 7 reducing their positions, and 8 closing their positions.
500% more call options, than puts
Call options by funds: $192K | Put options by funds: $32K
200% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 7
3% less funds holding
Funds holding: 60 → 58 (-2)
13% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 8
32% less capital invested
Capital invested by funds: $32.8M → $22.5M (-$10.3M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$1.82M |
| 2 |
AI
Ariel Investments
Chicago,
Illinois
|
+$499K |
| 3 |
Renaissance Technologies
New York
|
+$279K |
| 4 |
Morgan Stanley
New York
|
+$263K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$248K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$4.4M |
| 2 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$800K |
| 3 |
D.E. Shaw & Co
New York
|
-$470K |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$211K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$154K |
FRTX Hedge Fund Activity: Q2 2015 in Review
58 of the 3,713 institutional investors tracked by Wall St. Rank reported a position in Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) for Q2 2015, worth a combined $22.5M — down 32% from $32.8M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of FRTX and 7 opened new positions — a net loss of 1 holder — while 7 trimmed existing stakes and 21 added.
The largest buyer was Rock Springs Capital Management, opening a new position worth an estimated $1.82M. The largest seller was RA Capital Management, cutting an estimated $4.4M.
- 58 institutional investors held Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) as of Q2 2015, down from 60 in Q1 2015.
- Funds reported $22.5M of Fresh Tracks Therapeutics, Inc. Common Stock stock for Q2 2015, down 32% quarter-over-quarter.
- 7 funds opened new Fresh Tracks Therapeutics, Inc. Common Stock positions in Q2 2015 and 8 closed out, a net change of -1 holder.
- The largest Fresh Tracks Therapeutics, Inc. Common Stock buyer in Q2 2015 was Rock Springs Capital Management, an estimated $1.82M added.
- The largest Fresh Tracks Therapeutics, Inc. Common Stock seller in Q2 2015 was RA Capital Management, an estimated $4.4M sold.
Based on aggregated 13F filings for Q2 2015.